PRESS RELEASE published on 10/10/2023 at 07:00, 2 years 1 month ago Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)
PRESS RELEASE published on 10/02/2023 at 07:00, 2 years 2 months ago Cosmo and Hikma Sign License Agreement for Winlevi® in 17 Middle Eastern and North African Countries
PRESS RELEASE published on 09/27/2023 at 07:00, 2 years 2 months ago Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa
PRESS RELEASE published on 09/04/2023 at 07:00, 2 years 3 months ago Cosmo and Adalvo sign License and Supply Agreement for Rifamycin SV MMX® 200mg in Europe, APAC, MENA and LATAM regions
PRESS RELEASE published on 09/04/2023 at 06:45, 2 years 3 months ago Termination of Agreement for Rifamycin SV MMX® with Dr. Falk Pharma
PRESS RELEASE published on 07/26/2023 at 06:00, 2 years 4 months ago Cosmo presents strong H1 2023 operational and financial results
PRESS RELEASE published on 07/05/2023 at 07:15, 2 years 4 months ago Invitation to Cosmo’s Half-Year 2023 Webcast on 26 July 2023
PRESS RELEASE published on 06/29/2023 at 07:15, 2 years 5 months ago Cosmo announces the beginning of the phase III trials in males for the treatment of androgenetic alopecia
PRESS RELEASE published on 06/28/2023 at 07:15, 2 years 5 months ago Cosmo announces Cortiment® approval in Japan
PRESS RELEASE published on 06/22/2023 at 07:15, 2 years 5 months ago Cosmo and Hyundai Pharm Announce Signing of License Agreement for Winlevi® in Korea
Published on 12/05/2025 at 02:35, 3 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 16 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 11 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 16 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 46 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 25 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 51 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 1 minute ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 6 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 31 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 32 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 15 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
